Home > Support > GAMMAGARD LIQUID SubQ CoPay Card

Presenting the


Eligible patients with PI on a prescribed Shire Ig treatment with commercial insurance can save up to $5000* within a 12-month period on their out-of-pocket co-payment, co-insurance, or deductible for medication costs with MyIgCoPayCard. This program provides financial support for select Shire Ig treatments regardless of household income. Patients are eligible for a maximum benefit of $5000 in total Shire support in a 12-month period to:

  • Help patients with PI have access to Shire Ig treatment
  • Lessen the burden of out-of-pocket expenses for Shire Ig treatment

Enrollment in MyIgCoPayCard is easy–start today!

For more information, call MyIgSource at 855-250-5111.

Patients whose prescriptions are reimbursed, in whole or in part by Medicaid, Medicare, Medigap, VA, DoD, TRICARE or any other federal or state health care programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law, are not eligible for this offer. Commercial insurance must cover medication costs for prescribed Shire Immune Globulin (IG) treatment for primary immunodeficiency (PI) and allow for CoPay or coinsurance assistance. Shire reserves the right to change or discontinue this program at any time without notice. Please see full treatment specific Terms and Conditions on product websites for additional program restrictions and eligibility requirements or call MyIgSource for more information (855-250-5111).

Please See Full Terms and Conditions

  • MyIgSource is a patient support program for all PI patients and caregivers throughout your journey. Sign up to get access to experienced Patient and Nurse Advocates, get information about insurance and financial support, useful tools, and more.
    Learn More
  • Ask an Advocate Questions about PI or PI treatments? Our trained Patient and Nurse Advocates can help, and asking your question is easy with our Ask An Advocate feature.
    Start Getting Answers
  • Insurance Questions? MyIgSource is available by phone to answer your questions and can assist you with insurance information regarding your treatment. Call 1-855-250-5111 to learn more.
    See More Information

Gammagard Liquid MyIgCoPayCard Program Terms and Conditions

This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law

Shire's MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Shire IG (Immunoglobulin) products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.

To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Shire IG product with an ICD-10 for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Shire IG product and allows for CoPay assistance; and 3. be two (2) years old or older.

Acceptance of this offer must be consistent with the terms of benefits provided by patient's health insurance provider.

Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.

This program is only valid for residents of the United States.

Shire reserves the right to change or discontinue this program at any time without notice.

This is not health insurance.


Add to patient instructions:

If your insurance situation changes, it is your responsibility to notify MyIgSource's CoPay assistance program.

© 2017 Shire. All rights reserved.

SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates. Gammagard Liquid is a trademark or registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.

S30515 04/17

Please expand for Indication and Important Safety Information.


What is the most important information that I should know about GAMMAGARD LIQUID?

GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.